Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 44 peer-reviewed journal articles Updated
Metabolic Medicine · Classical Homocystinuria

Your Path Forward: Understanding Classical Homocystinuria

At a Glance

Classical homocystinuria (CBS deficiency) is a rare but highly manageable inherited metabolic disorder. Treatment focuses on keeping total homocysteine levels below 100 µmol/L using Vitamin B6, betaine, and a low-protein diet to prevent severe complications like blood clots and vision loss.

Receiving a diagnosis of Classical Homocystinuria (also called CBS deficiency) can feel overwhelming and unexpected. It is a rare condition, and it is natural to feel a sense of shock or uncertainty about the future. However, the most important thing to know right now is that this is a highly manageable condition with a well-established path for care [1][2]. By working closely with a metabolic specialist, you can significantly reduce the risks associated with the disease and support a healthy, active life [2][3].

For more detailed information, please explore the sections below:

01

The Biology of the Backup: Classification and Diagnosis

Learn how Classical Homocystinuria (CBS deficiency) is diagnosed. Understand the B6 challenge, target tHcy levels, and differences from Marfan syndrome.

02

Understanding the Impact: How Homocystinuria Affects the Body

Learn how classical homocystinuria affects the body. Understand the symptoms involving the eyes, bones, brain, and blood vessels, and why early treatment matters.

03

The Pillars of Care: Standard Treatment and New Horizons

Learn about standard treatments for Homocystinuria (CBS deficiency), including Vitamin B6, methionine-restricted diets, betaine, and new enzyme therapies.

04

Staying Ahead: Long-term Monitoring and Daily Life

Learn how to manage classical homocystinuria (CBS deficiency) in daily life. Understand long-term monitoring, building your care team, and emergency risks.

Understanding the Basics

Classical homocystinuria is an inherited metabolic disorder where the body lacks enough of an enzyme (a protein that triggers chemical reactions) called cystathionine beta-synthase (CBS) [1][4].

Under normal circumstances, this enzyme helps break down an amino acid (a building block of protein) called methionine. When the enzyme isn’t working correctly, a substance called homocysteine builds up to toxic levels in the blood and urine [1][4]. If left untreated, this “toxic buildup” can affect four major areas of the body: the eyes, the skeleton, the brain, and the blood vessels [1][5].

How Common Is It?

Classical homocystinuria is rare, but its frequency varies significantly by region:

  • Global Average: Often estimated around 1 in 200,000 to 1 in 344,000 people [1][6].
  • High-Frequency Areas: In some countries, such as Qatar, it may be as common as 1 in 1,800 [1].
  • Low-Frequency Areas: In other regions, it may be as rare as 1 in 900,000 [1].

Three Stabilizing Facts for Your Journey

While the diagnosis is serious, these three facts provide a foundation for hope and action:

  1. Treatment is Highly Effective: When managed correctly, the most severe complications—such as intellectual disability and life-threatening blood clots—are largely preventable [1][2].
  2. You Have a Target Goal: Medical consensus focuses on a clear, measurable goal: keeping the total homocysteine (tHcy) level in the blood below 100 µmol/L. Staying below this threshold dramatically lowers the risk of health issues [1].
  3. A “B6-Responsive” Path May Exist: Some people have a form of the condition that responds to high doses of Vitamin B6 (pyridoxine). For these individuals, the condition can often be managed more easily, sometimes even without a strict low-protein diet [1][7].

The Impact of Timing: Diagnosis and Outlook

The “course” of the condition depends heavily on when it is identified and how quickly treatment begins.

Feature Diagnosed at Birth (via Screening) Diagnosed Later (after symptoms)
Intellectual Ability Usually within the normal range [1][2]. May involve learning difficulties or delays if untreated [1][5].
Vision Highly likely to prevent ectopia lentis (dislocation of the eye lens) [1]. Lens dislocation is common but can be managed with surgery [8][9].
Vascular Risk Risk of blood clots is significantly minimized [1]. Higher risk of thromboembolism (blood clots) until levels are controlled [5][10].
Primary Goal Maintaining long-term health and growth [1]. Rapidly lowering homocysteine to prevent further complications [1][11].

The Consensus on Early Treatment

Medical experts worldwide agree that the “gold standard” for care is early and lifelong management [1][12]. The primary tools used to control the condition include:

  • Vitamin B6 (Pyridoxine): A doctor-supervised “challenge” determines if this vitamin can help the enzyme work better [1].
  • Dietary Management: Restricting methionine by limiting high-protein foods (like meat, dairy, and eggs) and using specialized medical formulas [1][13].
  • Betaine: A medication that provides an alternative pathway for the body to lower homocysteine levels [1][14].

Research confirms that patients who are diagnosed early through newborn screening and maintain consistent metabolic control can lead active, productive, and healthy lives [2][3].

Common questions in this guide

What is the target homocysteine level for treating classical homocystinuria?
The primary medical goal is to keep the total homocysteine level in your blood below 100 µmol/L. Maintaining this target dramatically lowers the risk of serious health issues, such as blood clots and intellectual delays.
What is a Vitamin B6 challenge and why is it important?
A Vitamin B6 challenge is a doctor-supervised test to see if your body responds to high doses of pyridoxine. If you are B6-responsive, your condition can often be managed more easily, sometimes even without a strict low-protein diet.
How does classical homocystinuria affect my eyes?
Without early treatment, the buildup of homocysteine can lead to ectopia lentis, which is the dislocation of the eye lens. Early diagnosis and consistent management significantly reduce the risk of this happening, though it can be treated with surgery if it occurs.
What does a methionine-restricted diet involve?
This specialized diet restricts methionine by strictly limiting high-protein foods like meat, dairy, and eggs. Patients often use special medical formulas to ensure they get the right nutrition without causing a toxic buildup of homocysteine.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is my (or my child's) current total homocysteine (tHcy) level, and what is our target goal?
  2. 2.Has a pyridoxine (Vitamin B6) challenge been performed, and are we considered 'B6-responsive'?
  3. 3.Who are the members of our metabolic care team (e.g., metabolic dietitian, ophthalmologist, hematologist)?
  4. 4.If we are not B6-responsive, what does a methionine-restricted diet look like for our family?
  5. 5.What are the specific signs of a blood clot or lens dislocation that I should watch for?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency.

    Morris AA, Kožich V, Santra S, et al.

    Journal of inherited metabolic disease 2017; (40(1)):49-74 doi:10.1007/s10545-016-9979-0.

    PMID: 27778219
  2. 2

    Outcomes after newborn screening for propionic and methylmalonic acidemia and homocystinurias.

    Reischl-Hajiabadi AT, Schnabel E, Gleich F, et al.

    Journal of inherited metabolic disease 2024; (47(4)):674-689 doi:10.1002/jimd.12731.

    PMID: 38563533
  3. 3

    Early Diagnosis of Classic Homocystinuria in Kuwait through Newborn Screening: A 6-Year Experience.

    Alsharhan H, Ahmed AA, Ali NM, et al.

    International journal of neonatal screening 2021; (7(3)) doi:10.3390/ijns7030056.

    PMID: 34449519
  4. 4

    Inborn errors of amino acid metabolism - from underlying pathophysiology to therapeutic advances.

    Ziegler SG, Kim J, Ehmsen JT, Vernon HJ

    Disease models & mechanisms 2023; (16(11)) doi:10.1242/dmm.050233.

    PMID: 37994477
  5. 5

    Proteomic exploration of cystathionine β-synthase deficiency: implications for the clinic.

    Jakubowski H

    Expert review of proteomics 2020; (17(10)):751-765 doi:10.1080/14789450.2020.1865160.

    PMID: 33320032
  6. 6

    Classical homocystinuria: A common inborn error of metabolism? An epidemiological study based on genetic databases.

    Weber Hoss GR, Sperb-Ludwig F, Schwartz IVD, Blom HJ

    Molecular genetics & genomic medicine 2020; (8(6)):e1214 doi:10.1002/mgg3.1214.

    PMID: 32232970
  7. 7

    Biomarkers of oxidative stress, inflammation, and vascular dysfunction in inherited cystathionine β-synthase deficient homocystinuria and the impact of taurine treatment in a phase 1/2 human clinical trial.

    Van Hove JLK, Freehauf CL, Ficicioglu C, et al.

    Journal of inherited metabolic disease 2019; (42(3)):424-437 doi:10.1002/jimd.12085.

    PMID: 30873612
  8. 8

    Parental Living Donor Liver Transplantation as a Solution in Medical Treatment-Resistant Cystathionine-β-Synthase Deficiency: A Single-Center Case Series.

    Huang YF, Wei L, Qu W, et al.

    Pediatric transplantation 2025; (29(1)):e70011 doi:10.1111/petr.70011.

    PMID: 39777818
  9. 9

    A refined total capsular bag suspension technique for lens subluxation from cystathionine beta-synthase deficiency: A case report and literature review.

    Lu Y, Jiang Y, Wang Z

    American journal of ophthalmology case reports 2024; (34()):102042 doi:10.1016/j.ajoc.2024.102042.

    PMID: 38544915
  10. 10

    Delayed diagnosis of homocystinuria presenting with coronavirus disease 2019 in a 17-year-old boy.

    Yakut N, Tuzun B, Ergun NU

    Revista da Sociedade Brasileira de Medicina Tropical 2022; (55()):e0143 doi:10.1590/0037-8682-0143-2022.

    PMID: 36134859
  11. 11

    A case series of cerebral venous thrombosis as the first manifestation of homocystinuria.

    Ochoa-Ferraro A, Wanninayake S, Dawson C, et al.

    European stroke journal 2021; (6(4)):420-427 doi:10.1177/23969873211059479.

    PMID: 35342812
  12. 12

    Newborn screening for homocystinuria.

    Walter JH, Jahnke N, Remmington T

    The Cochrane database of systematic reviews 2015; CD008840 doi:10.1002/14651858.CD008840.pub4.

    PMID: 26423208
  13. 13

    Betaine supplementation is less effective than methionine restriction in correcting phenotypes of CBS deficient mice.

    Gupta S, Wang L, Kruger WD

    Journal of inherited metabolic disease 2016; (39(1)):39-46 doi:10.1007/s10545-015-9883-z.

    PMID: 26231230
  14. 14

    Peripheral nerve involvement in classic homocystinuria: an unusual association.

    Oliveira Santos M, Geraldes R, Conceição I

    BMJ case reports 2016; (2016()) doi:10.1136/bcr-2016-216255.

    PMID: 27681349

This page provides educational information about Classical Homocystinuria and its management. It does not replace professional medical advice from your metabolic specialist or care team.

Get notified when new evidence is published on Homocystinuria due to cystathionine beta-synthase deficiency.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.